Suraj Kachgal
Seminars
Thursday 16th October 2025
Development of a CD3 VHH Platform that Enables the Rapid Testing of Multiple T-Cell Engager Configurations for Optimal Use Cases
1:30 pm
- Discussing the development of identifying and engineering a cyno-cross reactive CD3 VHH platform with properties suitable for either oncology or immunology
- Demonstrating the ease of evaluating multiple CD20 TCE configurations with the CD3 VHH binding arm to determine an optimal lead
- Brief overview on how a CD3 VHH simplifies the development of the next generation of T cell engagers
